In the past twelve months alone, the focused ultrasound field has experienced remarkable growth, indicating that the field is transitioning from “if” the technology will achieve widespread adoption to “when” it will become an international standard of care. In 2021, more than 92,000 patients were treated with focused ultrasound, in part thanks to almost 100 new commercial treatment sites. Nearly $400 million was invested in the industry, which grew by 14 percent with 11 new companies joining the field. Eleven new indications were identified, and on the other end of the spectrum, 21 new regulatory approvals were granted in 10 countries.
Every day, we are gratified and amazed by the focused ultrasound community that has contributed to bringing the field to this point. This includes our donors who have generously fueled our mission to revolutionize how devastating diseases like Alzheimer’s, Parkinson’s, and various forms of cancer are treated and managed. But considerable work remains for this noninvasive, therapeutic technology to achieve widespread adoption and become available to patients as a standard of care.
We invite you to join this revolution in medicine by making a gift and supporting our mission of accelerating the development and adoption of focused ultrasound. Your investment will lead to improved quality of life and longevity for millions of people by making this noninvasive, life-changing treatment available in the shortest time possible. We very much appreciate your interest and hope you will consider a gift to support the Foundation’s lifesaving mission.